` 722 (UMP Healthcare Holdings Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

722
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, UMP Healthcare Holdings Ltd has underperformed Hang Seng (Hong Kong), delivering a return of +13% compared to the Hang Seng (Hong Kong)'s +15% growth.

Stocks Performance
722 vs Hang Seng (Hong Kong)

Loading
722
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
722 vs Hang Seng (Hong Kong)

Loading
722
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
722 vs Hang Seng (Hong Kong)

Loading
722
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
UMP Healthcare Holdings Ltd vs Peers

Hang Seng (Hong Kong)
722
JXN
TNL
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

UMP Healthcare Holdings Ltd
Glance View

Market Cap
381.2m HKD
Industry
Health Care

UMP Healthcare Holdings Ltd is an investment company, which engages in the provision of healthcare services. The company employs 476 full-time employees The company went IPO on 2015-11-27. Together with its subsidiaries, the Company operates business through its two operating segments. The Clinical Healthcare Services segment is engaged in the provision of medical and dental services, health check-up and other auxiliary services include imaging and laboratory services, physiotherapy services and vision care services. The Corporate Healthcare Solution Services segment is engaged in the provision of corporate healthcare solutions to contract customers. The firm is also engaged in the health check-up business and the provision of professional training to doctors and nurses under its GOLD training programme in Mainland China.

Intrinsic Value
1.09 HKD
Undervaluation 57%
Intrinsic Value
Price
Back to Top